Anzeige
Mehr »
Samstag, 11.10.2025 - Börsentäglich über 12.000 News
Der Lithium Markt ist zurück - und Simon Clarke ist mit dabei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40F75 | ISIN: FR001400Q9V2 | Ticker-Symbol: H8Y
Tradegate
10.10.25 | 16:36
42,950 Euro
-0,69 % -0,300
1-Jahres-Chart
EXOSENS SA Chart 1 Jahr
5-Tage-Chart
EXOSENS SA 5-Tage-Chart
RealtimeGeldBriefZeit
42,75043,85013:04
43,10043,40010.10.

Aktuelle News zur EXOSENS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:22Theon International erwirbt 9,8 %-Anteil an Exosens für 268,7 Millionen Euro3
12:18Theon International to acquire 9.8% stake in Exosens for €268.7 million1
EXOSENS Aktie jetzt für 0€ handeln
12:10Theon International PLC: THEON plans to acquire 9.8% stake in Exosens257PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 11 October 2025 - Theon International Plchas entered into a de?nitive agreement with HLD Europe SCA, Invest Prince...
► Artikel lesen
01.10.DB starts coverage on Theon, Exosens as Europe's defense market expands16
29.09.Exosens secures major contract with the Spanish army for 17 000 advanced night vision monoculars193EXOSENS SECURES MAJOR CONTRACT WITH THE SPANISH ARMY FOR 17 000 ADVANCED NIGHT VISION MONOCULARS PRESS RELEASEMÉRIGNAC, FRANCE - SEPTEMBER, 29th 2025 Exosens announces that the Spanish Ministry of...
► Artikel lesen
09.09.Exosens launches its new 5G image intensifier tube, a game changer in terms of visual perception and performance in night vision18
27.08.Exosens extends its technology portfolio by signing an agreement to acquire Phasics, leader in high performance cameras based solutions for optical metrology433EXOSENS EXTENDS ITS TECHNOLOGY PORTFOLIO BY SIGNING AN AGREEMENT TO ACQUIRE PHASICS, LEADER IN HIGH PERFORMANCE CAMERAS BASED SOLUTIONS FOR OPTICAL METROLOGY PRESS RELEASEMÉRIGNAC, FRANCE- PALAISEAU...
► Artikel lesen
31.07.Exosens launches a share buyback programme20
30.07.Exosens announces the publication of its 2025 half-year financial report4
30.07.Exosens delivers strong H1 2025 performance in a highly-dynamic Defense market; Fully on track to 2025 guidance445Exosens delivers strong H1 2025 performance in a highly-dynamic Defense market Fully on track to 2025 guidance HIGHLIGHTS Sustained revenue growth of +20.1% to €224.5m in H1 2025, driven by Defense...
► Artikel lesen
16.07.Exosens accelerates innovation capabilities in night vision and expands total addressable market with strategic acquisition of NVLS9
07.07.Half-yearly report on Exosens' liquidity contract with Kepler Cheuvreux7
26.06.Kepler Cheuvreux downgrades Exosens stock on valuation concerns27
26.05.Exosens: Combined General Meeting of 23 May 2025681PRESS RELEASEMÉRIGNAC, FRANCE - 26 MAY 2025 COMBINED GENERAL MEETING OF 23 MAY 2025 The Combined General Meeting (ordinary and extraordinary) of Exosens shareholders (the 'Company') was held on Friday...
► Artikel lesen
30.04.Exosens: Availability of documents and information relating to the Combined General Meeting of 23 May 20257
30.04.Exosens: Availability of 2024 Universal Registration Document2
28.04.Exosens: Ein Hidden-Champion, den Sie kennen sollten1.224Exosens wächst mit erheblichem Tempo, ist profitabel, nicht sonderlich hoch bewertet, relativ klein und steht vor einem massiven Gewinnsprung Den vollständigen Artikel lesen ...
► Artikel lesen
28.04.Exosens reaffirms 2024 outlook as NATO demand lifts sales9
28.04.Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance728EXOSENS DELIVERS STRONG REVENUE GROWTH IN Q1 2025 IN A DYNAMIC DEFENSE MARKET ENVIRONMENT FULLY ON TRACK TO 2025 GUIDANCE HIGHLIGHTS Sustained revenue growth of +21.1% to €104.9m in Q1 2025, reflecting...
► Artikel lesen
06.03.Beneq Oy: Beneq and Exosens Collaborate on Lead-Free MCPs with ALD, Enhancing Precision, Performance, and Manufacturing Efficiency883ALD enables lead-free MCP production with precise thin-film deposition, enhancing manufacturing yields, device performance, and lifetime value. Exosens chose Beneq's P400A batch and TFS 500...
► Artikel lesen
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1